Cargando…
Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease
Sickle cell disease (SCD) is associated with severe morbidity and early mortality. Two large population studies found an increased risk for leukemia in individuals with SCD. Notably, while the relative risk of leukemia development is high, the absolute risk is low in individuals with SCD who do not...
Autores principales: | Gondek, Lukasz P., Sheehan, Vivien A., Fitzhugh, Courtney D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181510/ https://www.ncbi.nlm.nih.gov/pubmed/35683547 http://dx.doi.org/10.3390/jcm11113160 |
Ejemplares similares
-
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022) -
Clonal hematopoiesis in sickle cell disease
por: Liggett, L. Alexander, et al.
Publicado: (2022) -
Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies
por: Fitzhugh, Courtney D., et al.
Publicado: (2022) -
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?
por: Cumbo, Cosimo, et al.
Publicado: (2022) -
A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)